Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Symphony Financial Ltd. Co. boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.7% during the third quarter, Holdings Channel.com reports. The fund owned 4,966 shares of the biopharmaceutical company’s stock after buying an additional 179 shares during the quarter. Symphony Financial Ltd. Co.’s holdings in Gilead Sciences were worth $368,000 at […]
Cornerstone Wealth Management LLC increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.3% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 9,013 shares of the biopharmaceutical company’s stock after purchasing an additional 373 shares during the quarter. Cornerstone Wealth Management LLC’s holdings in Gilead Sciences were […]
Executive Wealth Management LLC reduced its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,689 shares of the biopharmaceutical company’s stock after selling 142 shares during the quarter. Executive […]
Ibex Wealth Advisors acquired a new position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 62,212 shares of the biopharmaceutical company’s stock, valued at approximately $4,662,000. Several other hedge funds have […]
SouthState Corp trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 16.8% in the third quarter, Holdings Channel.com reports. The firm owned 22,160 shares of the biopharmaceutical company’s stock after selling 4,468 shares during the quarter. SouthState Corp’s holdings in Gilead Sciences were worth $1,661,000 at the end of the […]